Shanghai Shen Lian Biomedical Corporation (SHA:688098)

China flag China · Delayed Price · Currency is CNY
6.00
+0.11 (1.87%)
Jun 9, 2025, 2:45 PM CST
32.45%
Market Cap 2.42B
Revenue (ttm) 294.10M
Net Income (ttm) -45.55M
Shares Out 410.64M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend 0.04 (0.59%)
Ex-Dividend Date Jun 14, 2024
Volume 2,423,020
Average Volume 2,855,741
Open 5.90
Previous Close 5.89
Day's Range 5.88 - 6.00
52-Week Range 3.63 - 6.34
Beta 0.62
RSI 57.18
Earnings Date Aug 29, 2025

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 391
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688098
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.